pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

6,122 catalysts · 5,539 phase readout · 2,295 8k filing · 343 pdufa · 240 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 47 catalysts2026-08-05: 18 catalysts2026-08-06: 12 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 2 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: phase readout×type: pdufa×clear all
type
  • phase readout5,539
  • 8k filing2,295
  • pdufa343
  • earnings240
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT06403280: The Effect of Alcohol on Common Tremor Syndromes

Sponsor: Medical University of Graz. Phase: NA. Conditions: Essential Tremor, Dystonia, Parkinson Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT03898180: Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Urothelial Carcinoma

full page →ctgov ↗
›TERMINATEDphase readoutNCT06315296: An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

Sponsor: Thomas Jefferson University. Phase: NA. Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Carcinoma, Metastatic Malignant Neoplasm in the Brain, Stage IV Lung Cancer AJCC v8

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07725796: A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

Sponsor: UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.. Phase: PHASE1. Conditions: Bladder (Urothelial, Transitional Cell) Cancer, NMIBC, Urothelial Carcinoma Bladder, Urothelial Carcinoma in Situ, Urothelial Carcinoma Recurrent, Urothelial Carcinoma of the Urinary Bladder, Non-Muscle Invasive Bladder Carcinoma, Non-muscle Invasive Bladder Cancer (NMIBC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06679062: Suvorexant for Treatment of AUD and PTSD

Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance. Phase: PHASE2. Conditions: Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD), Insomnia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04989946: Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer

Sponsor: University of Wisconsin, Madison. Phase: PHASE1. Conditions: Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07633288: A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses

Sponsor: SynAct Pharma Aps. Phase: PHASE2. Conditions: Respiratory Viral Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT07585903: The Effect of Family-Centered Care Practices In Pediatric Intensive Care Unit

Sponsor: Zonguldak Bulent Ecevit University. Phase: NA. Conditions: Pediatric Intensive Care

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06924827: A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex

Sponsor: Elizabeth Donner. Phase: PHASE4. Conditions: Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07003061: Sarcopenia and Neuromuscular Block in Gastrointestinal Cancer Surgery

Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Gastrointestinal Cancer, Sarcopenia, Neuromuscular Blockade

full page →ctgov ↗
›RECRUITINGphase readoutNCT05908461: The Early Childhood Friendship Project - Phase 3

Sponsor: State University of New York at Buffalo. Phase: NA. Conditions: Healthy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07674927: Pilot Study Exploring the Effects of Rhythmic Auditory Stimulation on Gait in People With Motor Incomplete Spinal Cord Injury

Sponsor: University of California, Davis. Phase: NA. Conditions: Spinal Cord Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT06826742: Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery

Sponsor: Mayo Clinic. Phase: PHASE4. Conditions: Cesarean Delivery

full page →ctgov ↗
›COMPLETEDphase readoutNCT01469442: Postoperative Biliary Fistula Prevention After Hepatectomy

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Hepatectomy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07533942: A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

Sponsor: Jazz Pharmaceuticals. Phase: PHASE2. Conditions: Meningioma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07667686: French Validation of the Recovery Assessment Scale (RAS-FR)

Sponsor: Etablissement Public de Santé Mentale de Metz-Jury. Phase: . Conditions: Mental Health, Psychiatric Disorders

full page →ctgov ↗
›RECRUITINGphase readoutNCT07026786: Using Mindfulness in an Enhanced Recovery After Surgery Protocol to Support Recovery After Colorectal Surgery

Sponsor: University Hospitals Cleveland Medical Center. Phase: NA. Conditions: Pain After Surgery, Anxiety After Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT07224061: Promoting Asthma Management Guidelines With Technology-Based Intervention and Care Coordination in Clinics and Schools

Sponsor: Montefiore Medical Center. Phase: NA. Conditions: Asthma in Children

full page →ctgov ↗
›RECRUITINGphase readoutNCT03598361: Mineral Status in Pregnant Women

Sponsor: Poznan University of Life Sciences. Phase: . Conditions: Pregnancy; Disorder, Blood

full page →ctgov ↗
›COMPLETEDphase readoutNCT05625061: Just-in-time Adaptive Intervention Messaging in a Digital Weight Loss Intervention for Young Adults

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Obesity, Overweight, Overweight and Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07667673: Multimodality RV Phenotyping for Risk Stratification and Short-Term Outcomes in Group 1 PAH

Sponsor: Istanbul University - Cerrahpasa. Phase: . Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension, Right Ventricular Function

full page →ctgov ↗
›COMPLETEDphase readoutNCT07551869: Oxygen as a Metabolic Modulator: Divergent Physiological Adaptations to Hypoxic and Hyperoxic Tabata Training.

Sponsor: Haute Ecole Bruxelles-Brabant. Phase: NA. Conditions: Hyperoxia / High FiO₂ Exposure, Interval Training, HIIT, High Intensity Interval Training, VO2max, Hypoxia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07668583: EFFICACY AND SAFETY OF ZOLEDRONATE VERSUS PLACEBO ON PAIN AT WEEK 12 IN PEDIATRIC PATIENTS WITH CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: Osteomyelitis Chronic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07676383: Precision Navigation to Improve Community Cancer Screening Participation

Sponsor: Hunan Cancer Hospital. Phase: NA. Conditions: Cancer Screening, Lung Cancer, Breast Cancer, Colorectal Cancer, Upper Gastrointestinal Cancer, Liver Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07673783: Outlining Biological Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients.

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Parkinson Disease (PD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07451483: Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

Sponsor: Jules Bordet Institute. Phase: . Conditions: Ventral Hernias, Cytoreductive Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT05934708: Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise

Sponsor: University of Southern California. Phase: NA. Conditions: Inflammatory Response

full page →ctgov ↗
›TERMINATEDphase readoutNCT03684876: Association Between Renal and Right Cardiac Functions After Urinary Sodium Depletion Following Cardiac Surgery

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Cardiorenal Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07579117: Endoscopic Video-Assisted Nipple-Sparing Mastectomy

Sponsor: European Institute of Oncology. Phase: NA. Conditions: Endoscopic Video-assisted Nipple-sparing Mastectomy, Breast Surgery, Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07603817: Association Between Overt and Sub-clinical Primary Hypothyroidism and Metabolic Dysfunction-Associated Steatoic Liver Disease in Non-Diabetic Patients

Sponsor: Sohag University. Phase: . Conditions: Overt, Sub-clinical, Primary Hypothyroidism, Metabolic Dysfunction-Associated Steatoic Liver Disease, Non-Diabetic Patients

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07334340: Modified vs Standard CDED: Evaluation of a Nordic Adaptation of Nutritional Therapy in Paediatric Crohn's Disease

Sponsor: Vastra Gotaland Region. Phase: NA. Conditions: Pediatric Crohns Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06931340: Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE3. Conditions: Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07667868: A Phase I, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of BP2202 in Patients With Relapsed/Refractory Multiple Myeloma

Sponsor: BrightPath Biotherapeutics Co., Ltd.. Phase: PHASE1. Conditions: Relapsed/Refractory Multiple Myeloma (RRMM)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07236268: Prevalence of HIV and Sexually Transmitted Infections in Migrant Communities in Slovakia

Sponsor: Comenius University. Phase: . Conditions: STIs, HIV, Rapid Detection

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05621850: Impact of CErebral Endovascular PROcedures on the Systemic Immune responSe Response

Sponsor: University Hospital, Limoges. Phase: NA. Conditions: Cerebral Arterio-venous Malformation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07571291: DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSIS

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: Pulmonary Fibrosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06094491: Virtual Diabetes Group Visits Across Health Systems

Sponsor: University of Chicago. Phase: NA. Conditions: T2DM (Type 2 Diabetes Mellitus), Hypertension, Heart Disease Chronic, Stroke, Hyperlipidemias, Peripheral Vascular Diseases, Obesity

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07260760: Clinical Comprehensive Evaluation of Neuroprotective Drugs for Acute Ischemic Stroke

Sponsor: Qianfoshan Hospital. Phase: . Conditions: Acute Ischemic Stroke

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07493460: Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines

Sponsor: Washington University School of Medicine. Phase: PHASE4. Conditions: Immunology, Healthy Adults

full page →ctgov ↗
›COMPLETEDphase readoutNCT04273360: Restrictive Use of Restraints and Delirium Duration in ICU

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Restraint, Physical, Mechanical Ventilation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07414160: Association Between Dynamic Prealbumin Trajectories and Prognosis in Critically Ill Patients

Sponsor: The First Hospital of Jilin University. Phase: . Conditions: ICU, Critical Illness, Adult

full page →ctgov ↗
›RECRUITINGphase readoutNCT07588360: Haplo-Cord HSCT for AML/MDS

Sponsor: Fujian Medical University Union Hospital. Phase: NA. Conditions: MDS (Myelodysplastic Syndrome), AML (Acute Myeloid Leukemia)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05304715: Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection

Sponsor: Hellenic Institute for the Study of Sepsis. Phase: PHASE2. Conditions: Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome, Clostridioides Difficile Infection Recurrence, Mortality

full page →ctgov ↗
›COMPLETEDphase readoutNCT07363915: Group Program vs Single-Session Depathologizing Intervention for Subthreshold Anxiety-Depression in Primary Care (Spain)

Sponsor: University of Alcala. Phase: NA. Conditions: Anxiety, Depressive Symptoms, Anxiety Symptoms, Subthreshold Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT06453525: PrediSuisse: Automatized Assessment of Difficult Airway

Sponsor: Centre Hospitalier Universitaire Vaudois. Phase: . Conditions: Anesthesia, Intubation; Difficult or Failed, Airway Complication of Anesthesia

full page →ctgov ↗
›RECRUITINGphase readoutNCT05036226: COAST Therapy in Advanced Solid Tumors and Prostate Cancer

Sponsor: Medical University of South Carolina. Phase: PHASE1. Conditions: Prostate Cancer Recurrent, Solid Tumor, Adult

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03965689: Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Metastatic Lung Non-Small Cell Squamous Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8, Unresectable Lung Non-Small Cell Carcinoma, Unresectable Lung Non-Squamous Non-Small Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07661368: Cooking Health-Oriented Meals to Prevent Dementia and Diabetes

Sponsor: Virginia Polytechnic Institute and State University. Phase: NA. Conditions: Type 2 Diabetes, Dementia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07227168: A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Sponsor: Sutro Biopharma, Inc.. Phase: PHASE1. Conditions: Head and Neck Squamous Cell Carcinoma HNSCC, Non-Small Cell Lung Cancer NSCLC, Esophageal Cancer, Gastric Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma (PDAC), Cervical Cancer, Endometrial Cancer, Urothelial Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05983068: A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

Sponsor: Sanofi. Phase: PHASE4. Conditions: Dermatitis Atopic

full page →ctgov ↗
← prev
page 115 of 123
next →